Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
MRS in presymptomatic MAPT mutation carriers
2010
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Classification of primary progressive aphasia and its variants
2011 Standout
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations
1999
Cochrane Database of Systematic Reviews
2003 Standout
Comprehensive Examination of Therapies for Pain in Parkinson’s Disease: A Systematic Review and Meta-Analysis
2018
Progressive delayed‐onset dystonia after cerebral anoxic insult in adults
2002
DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task
2000 StandoutNobel
Phenotypic presentation of frontotemporal dementia with Parkinsonism‐chromosome 17 type P301S in a patient of Jewish‐Algerian origin
2003
The detection of preclinical Parkinson's disease: What is the role of positron emission tomography?
1993
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Management of acute organophosphorus pesticide poisoning
2007 Standout
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
1999
Motor Neuron Disease With Parkinsonism
1996
Burden of liver diseases in the world
2018 Standout
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Drugs Used to Treat Spasticity
2000
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study
2007
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Botulinum Toxin as a Biological Weapon
2001 Standout
Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies
1998
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
2006 Standout
Association between Parkinson’s Disease and Exposure to Pesticides in Southwestern France
2003
Structure-Guided Directed Evolution of Highly Selective P450-Based Magnetic Resonance Imaging Sensors for Dopamine and Serotonin
2012 StandoutNobel
Pesticides and Risk of Parkinson Disease
2005
Epidemiology of Parkinson's disease
2006 Standout
The genetics and neuropathology of Parkinson’s disease
2012
Amyotrophic lateral sclerosis
2011 Standout
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
2004
Taenia solium cysticercosis
2003 Standout
Genetic aspects of Parkinson's disease
1998
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Therapeutic Uses of Botulinum Toxin
1991
Control of goal-directed and stimulus-driven attention in the brain
2002 Standout
Parkinson's disease
2009 Standout
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
2007 Standout
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
2003
The Reorienting System of the Human Brain: From Environment to Theory of Mind
2008 Standout
Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
1994
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
2005 Standout
Environmental Risk Factors and Parkinson's Disease: A Metaanalysis
2001
Parkinson's disease
2015 Standout
Botulinum Toxin Type A as a Migraine Preventive Treatment
2000
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations
2007
Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits
2001
Polyisoprenylation Potentiates the Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase and the Cell Degenerative Effects of Sulfonyl Fluorides
2011
Scopolamine Treatment for Severe Extra-Pyramidal Signs Following Organophosphate (Chlorpyrifos) Ingestion
2005
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
2002 StandoutNobel
Dissociated neglect behavior following sequential strokes in the right hemisphere
1990
The Role of the Golgi-Resident SPCA Ca2+/Mn2+ Pump in Ionic Homeostasis and Neural Function
2011
Parkinson's Disease
1998 Standout
Reflex sympathetic dystrophy: changing concepts and taxonomy
1995 Standout
Transmembrane Signalling Systems in the Brain of Patients with Parkinson's Disease
1993
Chronic Back Pain Is Associated with Decreased Prefrontal and Thalamic Gray Matter Density
2004 Standout
Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy
2004
Non-motor features of Parkinson disease
2017 Standout
A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
1999
Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms
1998
Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome
2006
Systematic analysis of gene expression in human brains before and after death
2005 StandoutNobel
Amyotrophic Lateral Sclerosis
2001 Standout
Parkinson's Disease
2003 Standout
The molecular pathology of Alzheimer's disease
1991 Standout
Residual spinothalamic tract pathways predict development of central pain after spinal cord injury
2008
Pharmacology and Clinical Drug Candidates in Redox Medicine
2015
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
2012
Manganese and Parkinson’s Disease: A Critical Review and New Findings
2010
Therapeutic prospects for Parkinson disease
2013
A PET study of visuospatial attention
1993 Standout
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
2002 Standout
Wireless Instantaneous Neurotransmitter Concentration System: electrochemical monitoring of serotonin using fast-scan cyclic voltammetry—a proof-of-principle study
2010
Part 9: Post–Cardiac Arrest Care
2010 Standout
Health Effects of Chronic Pesticide Exposure: Cancer and Neurotoxicity
2004 Standout
Hydrogel bioelectronics
2018 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Spatial attention and neglect: parietal, frontal and cingulate contributions to the mental representation and attentional targeting of salient extrapersonal events
1999
Neural Science
2000 StandoutNobel
Ethenesulfonyl Fluoride (ESF): An On-Water Procedure for the Kilogram-Scale Preparation
2016 StandoutNobel
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Cannabinoids for Medical Use
2015 Standout
A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation
2000
Investigating the functional link between TMEM165 and SPCA1
2019 StandoutNobel
Deep brain stimulation for Parkinson’s disease
2003
Anti-spasticity agents for multiple sclerosis
2003
Interventions for fatigue in Parkinson's disease
2015
Works of Mohit Bhatt being referenced
PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report.
1993
Treatment of spasticity with botulinum toxin: A double‐blind study
1990
DISSEMINATED CYSTICERCOSIS
1988
Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning
1993
Reversible Parkinsonism and T1W pallidal hyperintensities in acute liver failure
2006
A randomized, double‐blind, placebo‐controlled trial of safinamide as add‐on therapy in early Parkinson's disease patients
2011
The causalgia—dystonia syndrome
1993
Positron emission tomography in Shy‐Drager syndrome
1990
Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease
2002
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration
1992
Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow
1991
The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
1991
Bilateral subthalamic nucleus stimulation for Parkinson's disease.
2003
Wilson Disease Mutation Pattern with Genotype‐Phenotype Correlations from Western India: Confirmation of p.C271* as a Common Indian Mutation and Identification of 14 Novel Mutations
2013
Advances in Treatment of Wilson Disease
2017
Acute and reversible parkinsonism due to organophosphate pesticide intoxication
1999
Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations
2013
Long‐term efficacy and safety of safinamide as add‐on therapy in early P arkinson's disease
2012
Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease
2014
Advances in Treatment of Wilson Disease
2018
Time course of postanoxic akinetic‐rigid and dystonic syndromes
1993